Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (Avastin)

Retina

Volumn 29, Issue 7, 2009, Pages 926-931

  Lo, Wayne R ^a,c   Kim, Stephen J ^a,b   Aaberg Sr , Thomas M ^a   Bergstrom, Christopher ^a   Srivastava, Sunil K ^a   Yan, Jiong ^a   Martin, Daniel F ^a   Hubbard III, G Baker ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Avastin; Bevacizumab; Diabetes; Proliferative diabetic retinopathy; Vitrectomy; Vitreous hemorrhage

Indexed keywords

BEVACIZUMAB;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREMEDICATION; PREOPERATIVE PERIOD; RECURRENT DISEASE; SURGICAL INSTRUMENT; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

ADULT; ANTIBODIES, MONOCLONAL; COHORT STUDIES; DIABETIC RETINOPATHY; HUMANS; INCIDENCE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 68249091059     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181a8eb88     Document Type: Article

References (21)

1. Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. II. Post-operative complications. Ophthalmology 1983;90:522-530.
2. Novak M, Rice T, Michels R. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology 1984;91:1485-1489. (Pubitemid 15197020)
3. Blankenship GW. Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. Ophthalmology 1986;93:39-44.
4. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology 1989;96:1495-1500. (Pubitemid 19250960)
5. Neely KA, Scroggs MW, McCuen BW II. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes. Am J Ophthalmol 1998;126:82-90.
6. Yeh PT, Yang CM, Yang CH, Huang JS. Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study. Ophthalmology 2005;112:2095-2102.
7. Yang CM, Yeh PT, Yang CH. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy. Ophthalmology 2007;114:710-715.
8. Martin DF, McCuen BW II. Efficacy of fluid-air exchange for postvitrectomy diabetic vitreous hemorrhage. Am J Ophthalmol 1992;114:457-463.
9. Han DP, Murphy ML, Mieler WF, Abrams GW. Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage. Long-term results and complications. Retina 1991;11:309-314.
10. Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 2006;26:699-700. (Pubitemid 44620378)
11. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695. e1-e15. (Pubitemid 44442453)
12. Spaide RF, Fisher YL. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina 2006;26:275-278. (Pubitemid 44318179)
13. Avery RL. Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006;26:352-354. (Pubitemid 44318195)
14. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007;18:502-508. (Pubitemid 351339405)
15. Manzano RP, Peyman GA, Khan P, et al. Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin). Br J Ophthalmol 2007;91:804-807. (Pubitemid 46846656)
16. Arevalo JF, Maia M, Flynn HW Jr, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-216. (Pubitemid 351224097)
17. Yang CM, Yeh PT, Yang CH, Chen MS. Bevacizumab pretreatment and long-acting gas infusion on vitreous clear-up after diabetic vitrectomy. Am J Ophthalmol 2008;146:211-217.
18. Joondeph BC, Blankenship GW. Hemostatic effects of air versus fluid in diabetic vitrectomy. Ophthalmology 1989;96:1701-1706; discussion: 6-7.
19. Koutsandrea CN, Apostolopoulos MN, Chatzoulis DZ, Parikakis EA, Theodossiadis GP. Hemostatic effects of SF6 after diabetic vitrectomy for vitreous hemorrhage. Acta Ophthalmol Scand 2001;79:34-38.
20. Michels RG, Rice TA, Rice EF. Vitrectomy for diabetic vitreous hemorrhage. Am J Ophthalmol 1983;95:12-21.
21. Rice TA, Michels RG, Rice EF. Vitrectomy for diabetic traction retinal detachment involving the macula. Am J Ophthalmol 1983;95:22-33. (Pubitemid 13174290)